U.S. FDA Approves Expanded Use Of J & J's Cancer Cell Therapy U.S. FDA Approves Expanded Use Of J & J's Cancer Cell Therapy
The U.S. Food and Drug Administration on Friday allowed the expanded use of Johnson& Johnson and Legend Biotech ' s Carvykti cell therapy as an earlier treatment for...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Medicare IHC Claims With Melanoma Dxs Increased, Study Finds Medicare IHC Claims With Melanoma Dxs Increased, Study Finds
With sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 5, 2024 Category: Cancer & Oncology Tags: Dermatology Source Type: news

Oncology Practice and Lab to Pay $4 Million in Kickback Case Oncology Practice and Lab to Pay $4 Million in Kickback Case
San Antonio –based healthcare providers have agreed to pay over $4 million in civil settlements to resolve allegations of violating the False Claims Act through an unlawful kickback arrangement.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Prostate Cancer Tsunami Coming, Experts Caution Prostate Cancer Tsunami Coming, Experts Caution
A Lancet commission is predicting an 85% increase in deaths from the disease by 2040.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 5, 2024 Category: Cancer & Oncology Tags: Urology Source Type: news

Word Choice and Royals: The Need To Be Clear and Precise Word Choice and Royals: The Need To Be Clear and Precise
Dr Mark Lewis discusses the importance of word choice related to cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 4, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

' Nothing Rivaled This': Navigating the Cancer Drug Shortage'Nothing Rivaled This': Navigating the Cancer Drug Shortage
Because this platinum drug shortage crisis won ' t be the last, oncology practices need to be better prepared to tackle future problems.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 4, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Polygenic Risk Scores Improve Breast Cancer Screening Polygenic Risk Scores Improve Breast Cancer Screening
A Finnish study shows that adding polygenic risk scores to positive family histories and breast cancer-associated gene mutations improves risk stratification for breast cancer screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Certain Pesticides Linked With Risk for Pancreatic Cancer Certain Pesticides Linked With Risk for Pancreatic Cancer
The incidence of pancreatic adenocarcinoma has been increasing steadily for more than 30 years.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Diagnose Left Flank Pain in a 61-Year-Old Man Diagnose Left Flank Pain in a 61-Year-Old Man
Are you familiar with the presentation, differential diagnosis, and workup for renal cell carcinoma? Dr Karl J. D ' Silva provides a brief guide.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

FDA OKs Danicopan for Extravascular Hemolysis in PNH FDA OKs Danicopan for Extravascular Hemolysis in PNH
A tablet has been approved for a common complication during treatment for a rare blood disorder.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

New Trials in Prostate Cancer: Could Your Patient Benefit? New Trials in Prostate Cancer: Could Your Patient Benefit?
Perhaps one of your patients could benefit from a clinical trial that has recently opened in prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

It Takes a Village: Treating Patients for NSCLC Brain Mets It Takes a Village: Treating Patients for NSCLC Brain Mets
Treatment decisions for patients with NSCLC metastasized to the brain should involve a multidisciplinary team, considering factors such as immunotherapy efficacy and optimal treatment sequences.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Addressing Sexual Dysfunction in Women's Cancers Addressing Sexual Dysfunction in Women's Cancers
Many women with cancer want advice for managing sexual function issues, and clinicians are tuning in, new studies suggest.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

' Quad Shot' RT, Immunotherapy Improves Local Control in HNC'Quad Shot' RT, Immunotherapy Improves Local Control in HNC
A palliative Quad Shot radiotherapy regimen alongside concurrent immunotherapy can improve local control in symptomatic patients with head and neck cancer but may not improve overall survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Active Surveillance Doesn't Increase Malpractice Risk Active Surveillance Doesn't Increase Malpractice Risk
Physicians should feel reassured in recommending active surveillance as a management strategy for low-risk cancers, as no successful malpractice cases related to this approach have been found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news